FI933165A0 - Nya fosfolipidderivat - Google Patents

Nya fosfolipidderivat

Info

Publication number
FI933165A0
FI933165A0 FI933165A FI933165A FI933165A0 FI 933165 A0 FI933165 A0 FI 933165A0 FI 933165 A FI933165 A FI 933165A FI 933165 A FI933165 A FI 933165A FI 933165 A0 FI933165 A0 FI 933165A0
Authority
FI
Finland
Prior art keywords
derivatives
phospholipide
nya
medicaments
preparation processes
Prior art date
Application number
FI933165A
Other languages
English (en)
Other versions
FI111262B (fi
FI933165A (fi
Inventor
Gerhard Noessner
Bernhard Kutscher
Juergen Engel
Wolfgang Schumacher
Jurij Stekar
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of FI933165A0 publication Critical patent/FI933165A0/fi
Publication of FI933165A publication Critical patent/FI933165A/fi
Application granted granted Critical
Publication of FI111262B publication Critical patent/FI111262B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532Seven-(or more) membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
FI933165A 1992-07-11 1993-07-09 Menetelmä terapeuttisesti käyttökelpoisten fosfolipidijohdannaisten valmistamiseksi FI111262B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (de) 1992-07-11 1992-07-11 Neue Phospholipidderivate
DE4222910 1992-07-11

Publications (3)

Publication Number Publication Date
FI933165A0 true FI933165A0 (fi) 1993-07-09
FI933165A FI933165A (fi) 1994-01-12
FI111262B FI111262B (fi) 2003-06-30

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933165A FI111262B (fi) 1992-07-11 1993-07-09 Menetelmä terapeuttisesti käyttökelpoisten fosfolipidijohdannaisten valmistamiseksi

Country Status (31)

Country Link
EP (1) EP0579939B1 (fi)
JP (1) JP3311431B2 (fi)
KR (1) KR100297180B1 (fi)
CN (1) CN1039012C (fi)
AT (1) ATE176477T1 (fi)
AU (1) AU664101B2 (fi)
BR (1) BR9302809A (fi)
CA (2) CA2100228C (fi)
CZ (1) CZ290863B6 (fi)
DE (2) DE4222910A1 (fi)
DK (1) DK0579939T3 (fi)
EE (1) EE03140B1 (fi)
ES (1) ES2129053T3 (fi)
FI (1) FI111262B (fi)
GR (1) GR3029602T3 (fi)
HR (1) HRP931046B1 (fi)
HU (1) HU218783B (fi)
IL (1) IL106289A (fi)
LT (1) LT3113B (fi)
LV (1) LV10870B (fi)
MX (1) MX9304133A (fi)
NO (1) NO306468B1 (fi)
PL (3) PL177811B1 (fi)
RU (1) RU2108336C1 (fi)
SG (1) SG46249A1 (fi)
SI (1) SI9300365B (fi)
SK (1) SK283827B6 (fi)
TW (1) TW304956B (fi)
UA (1) UA40567C2 (fi)
YU (1) YU49079B (fi)
ZA (1) ZA934971B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0606480A (pt) 2005-01-21 2008-03-11 Astex Therapeutics Ltd compostos farmacêuticos
KR101378005B1 (ko) * 2005-12-19 2014-03-27 아에테르나 젠타리스 게엠베하 세포독성이 감소된 알킬 인지질 유도체 및 이의 용도
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050327B1 (de) * 1980-10-21 1984-06-20 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
CA1280369C (en) * 1985-12-04 1991-02-19 Hansjorg Eibl Pharmaceutical with anti-tumor effect
ES2036210T3 (es) * 1986-07-14 1993-05-16 Nippon Chemiphar Co., Ltd. Un procedimiento para la preparacion de un derivado de glicerol.
ES2058260T3 (es) * 1987-03-24 1994-11-01 Nippon Chemiphar Co Un proceso para la preparacion de un derivado del glicerol.
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
JPH0733791A (ja) 1995-02-03
HU9301992D0 (en) 1993-09-28
NO932502D0 (no) 1993-07-08
ES2129053T3 (es) 1999-06-01
SK67093A3 (en) 1995-03-08
EP0579939A1 (de) 1994-01-26
ZA934971B (en) 1994-02-01
CZ124993A3 (en) 1995-03-15
UA40567C2 (uk) 2001-08-15
PL299624A1 (en) 1994-02-21
CA2511753C (en) 2007-09-25
LTIP620A (en) 1994-07-15
GR3029602T3 (en) 1999-06-30
SK283827B6 (sk) 2004-02-03
EP0579939B1 (de) 1999-02-03
LV10870A (lv) 1995-10-20
HU218783B (hu) 2000-12-28
CA2100228C (en) 2006-01-24
FI111262B (fi) 2003-06-30
LV10870B (en) 1996-06-20
YU47393A (sh) 1997-08-22
NO306468B1 (no) 1999-11-08
KR100297180B1 (ko) 2001-11-30
DK0579939T3 (da) 1999-09-20
SI9300365B (sl) 2002-02-28
IL106289A (en) 2000-06-01
HUT64548A (en) 1994-01-28
CA2511753A1 (en) 1994-01-12
HRP931046A2 (en) 1997-04-30
CN1084175A (zh) 1994-03-23
SG46249A1 (en) 1998-02-20
ATE176477T1 (de) 1999-02-15
CN1039012C (zh) 1998-07-08
SI9300365A (en) 1994-03-31
KR940002265A (ko) 1994-02-17
TW304956B (fi) 1997-05-11
HRP931046B1 (en) 2000-06-30
RU2108336C1 (ru) 1998-04-10
NO932502L (no) 1994-01-12
JP3311431B2 (ja) 2002-08-05
YU49079B (sh) 2003-08-29
LT3113B (en) 1994-12-27
FI933165A (fi) 1994-01-12
MX9304133A (es) 1994-04-29
IL106289A0 (en) 1994-04-12
AU664101B2 (en) 1995-11-02
BR9302809A (pt) 1994-03-15
AU4186493A (en) 1994-01-13
CZ290863B6 (cs) 2002-11-13
DE4222910A1 (de) 1994-01-13
CA2100228A1 (en) 1994-01-12
EE03140B1 (et) 1998-12-15
PL175607B1 (pl) 1999-01-29
PL177811B1 (pl) 2000-01-31
DE59309355D1 (de) 1999-03-18
PL173388B1 (pl) 1998-02-27

Similar Documents

Publication Publication Date Title
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
FI933165A0 (fi) Nya fosfolipidderivat
DE58902310D1 (de) Tetrahydropyridin-derivate.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AETERNA ZENTARIS GMBH

Free format text: AETERNA ZENTARIS GMBH

MA Patent expired